FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

France Javoy-Agid

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Sheela Vyas; France Javoy-Agid; María-Trinidad Herrero; O Strada; F Boissiere; U Hibner; Yves Agid
Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders.
C Gargalidis-Moudanos; Nathalie Pizzinat; France Javoy-Agid; A Remaury; angelo parini
I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease.
P Anglade; Sheela Vyas; France Javoy-Agid; María-Trinidad Herrero; Patrick P Michel; J Marquez; Annick Mouatt-Prigent; Merle Ruberg; Etienne C Hirsch; Yves Agid
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of France Javoy-Agid (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1997: Sheela Vyas; France Javoy-Agid; María-Trinidad Herrero; O Strada; F Boissiere; U Hibner; Yves Agid
Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders.
Journal of neurochemistry 1997;69(1):223-31.
1997: C Gargalidis-Moudanos; Nathalie Pizzinat; France Javoy-Agid; A Remaury; angelo parini
I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease.
Neurochemistry international 1997;30(1):31-6.
1997: P Anglade; Sheela Vyas; France Javoy-Agid; María-Trinidad Herrero; Patrick P Michel; J Marquez; Annick Mouatt-Prigent; Merle Ruberg; Etienne C Hirsch; Yves Agid
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Histology and histopathology 1997;12(1):25-31.
1996: Gianni Pezzoli; O Strada; Vincenzo Silani; A Zecchinelli; Luigi Perbellini; France Javoy-Agid; P Ghidoni; E D Motti; T Masini; Guglielmo Scarlato; Yves Agid; Etienne C Hirsch
Clinical and pathological features in hydrocarbon-induced parkinsonism.
Annals of neurology 1996;40(6):922-5.
1996: M Chritin; V Blanchard; Rita Raisman-Vozari; Claude Feuerstein; Yves Agid; France Javoy-Agid; M Savasta
DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
The European journal of neuroscience 1996;8(12):2511-20.
1996: J Guridi; María-Trinidad Herrero; Maria Rosario Luquin; Javier Guillén; Merle Ruberg; J Laguna; Miquel Vila; France Javoy-Agid; Yves Agid; Etienne C Hirsch; Jose A Obeso
Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.
Brain : a journal of neurology 1996;119 ( Pt 5)():1717-27.
1996: María-Trinidad Herrero; R Levy; Merle Ruberg; Maria Rosario Luquin; J Villares; J Guillen; Baptiste A Faucheux; France Javoy-Agid; J Guridi; Yves Agid; Jose A Obeso; Etienne C Hirsch
Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum.
Neurology 1996;47(1):219-24.
1996: Miquel Vila; María-Trinidad Herrero; R Levy; Baptiste A Faucheux; Merle Ruberg; J Guillen; Maria Rosario Luquin; J Guridi; France Javoy-Agid; Yves Agid; Jose A Obeso; Etienne C Hirsch
Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.
Neurology 1996;46(3):802-9.
1996: M Gu; M T Gash; V M Mann; France Javoy-Agid; J Mark Cooper; Anthony H V Schapira
Mitochondrial defect in Huntington's disease caudate nucleus.
Annals of neurology 1996;39(3):385-9.
1996: Nathalie Griffon; Marc-Antoine Crocq; C Pilon; M P Martres; A Mayerova; G Uyanik; Edgar Burgert; Fabrice Duval; Jean-Paul Macher; France Javoy-Agid; Carol A Tamminga; Jean-Charles Schwartz; Pierre Sokoloff
Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia.
American journal of medical genetics 1996;67(1):63-70.
1996: María-Trinidad Herrero; R Levy; Merle Ruberg; France Javoy-Agid; Maria Rosario Luquin; Yves Agid; Etienne C Hirsch; Jose A Obeso
Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.
Advances in neurology 1996;69():209-16.
1996: P Anglade; V Blanchard; Rita Raisman-Vozari; Baptiste A Faucheux; María-Trinidad Herrero; Jose A Obeso; Annick Mouatt-Prigent; A Kastner; O Strada; France Javoy-Agid; Yves Agid; Etienne C Hirsch
Is dopaminergic cell death accompanied by concomitant nerve plasticity?
Advances in neurology 1996;69():195-208.
1995: María-Trinidad Herrero; S J Augood; Etienne C Hirsch; France Javoy-Agid; Maria Rosario Luquin; Yves Agid; Jose A Obeso; P C Emson
Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
Neuroscience 1995;68(4):1189-98.
1995: Baptiste A Faucheux; María-Trinidad Herrero; J Villares; R Levy; France Javoy-Agid; Jose A Obeso; JEAN-JACQUES HAUW; Yves Agid; Etienne C Hirsch
Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys.
Brain research 1995;691(1-2):115-24.
1995: R Levy; María-Trinidad Herrero; Merle Ruberg; J Villares; Baptiste A Faucheux; J Guridi; J Guillen; Maria Rosario Luquin; France Javoy-Agid; Jose A Obeso
Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons in the striatum in MPTP-treated monkeys and Parkinson's disease: an in situ hybridization study of GAD67 mRNA.
The European journal of neuroscience 1995;7(6):1199-209.
1995: V Blanchard; M Chritin; Sheela Vyas; M Savasta; Claude Feuerstein; Yves Agid; France Javoy-Agid; Rita Raisman-Vozari
Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain.
Journal of neurochemistry 1995;64(4):1669-79.
1995: Merle Ruberg; D Scherman; France Javoy-Agid; Yves Agid
Dopamine denervation, age of onset, and Parkinson's disease.
Neurology 1995;45(2):392.
1995: P Anglade; S Tsuji; France Javoy-Agid; Yves Agid; Etienne C Hirsch
Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
Annals of neurology 1995;37(2):265-72.
1995: R Levy; Merle Ruberg; María-Trinidad Herrero; J Villares; France Javoy-Agid; Yves Agid; Etienne C Hirsch
Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.
Neurology 1995;45(1):127-34.
1994: J Villares; O Strada; Baptiste A Faucheux; France Javoy-Agid; Yves Agid; Etienne C Hirsch
Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease.
Neuroscience letters 1994;182(1):59-62.
1994: B Grima; D Zelenika; France Javoy-Agid; Bernard Pessac
Identification of new human myelin basic protein transcripts in the immune and central nervous systems.
Neurobiology of disease 1994;1(1-2):61-6.
1994: Stéphane Lehéricy; Jean-Philippe Brandel; Etienne C Hirsch; P Anglade; J Villares; D Scherman; Charles Duyckaerts; France Javoy-Agid; Yves Agid
Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
Brain research 1994;659(1-2):1-9.
1994: A M Lorinet; France Javoy-Agid; M Laburthe; B Amiranoff
Galanin receptors in human hypothalamus: biochemical and structural analysis.
European journal of pharmacology 1994;269(1):59-64.
1994: jeswinder sian; David T Dexter; Andrew J Lees; Susan E Daniel; Yves Agid; France Javoy-Agid; Peter Jenner; CD Marsden
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Annals of neurology 1994;36(3):348-55.
1994: A Kastner; P Anglade; C Bounaix; Philippe Damier; France Javoy-Agid; N Bromet; Yves Agid; Etienne C Hirsch
Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system.
Neuroscience 1994;62(2):449-57.
1994: A Kastner; María-Trinidad Herrero; Etienne C Hirsch; J Guillen; Maria Rosario Luquin; France Javoy-Agid; Jose A Obeso; Yves Agid
Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
Annals of neurology 1994;36(2):206-14.
1994: P Dournaud; P Cervera-Pierot; Etienne C Hirsch; France Javoy-Agid; Claude Kordon; Yves Agid; Jacques Epelbaum
Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.
Neuroscience 1994;61(4):755-64.
1994: P Zhang; P Anglade; Etienne C Hirsch; France Javoy-Agid; Yves Agid
Distribution of manganese-dependent superoxide dismutase in the human brain.
Neuroscience 1994;61(2):317-30.
1994: G Boka; P Anglade; David Wallach; France Javoy-Agid; Yves Agid; Etienne C Hirsch
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.
Neuroscience letters 1994;172(1-2):151-4.
1994: S Holemans; France Javoy-Agid; Yves Agid; F De Paermentier; E C Laterre; Jean-Marie Maloteaux
Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease.
Brain research 1994;642(1-2):327-33.
1994: George R. Uhl; D Walther; Deborah C Mash; B Faucheux; France Javoy-Agid
Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.
Annals of neurology 1994;35(4):494-8.
1994: V Blanchard; Rita Raisman-Vozari; Sheela Vyas; Patrick P Michel; France Javoy-Agid; George R. Uhl; Yves Agid
Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.
Brain research. Molecular brain research 1994;22(1-4):29-38.
1994: France Javoy-Agid
Cholinergic and peptidergic systems in PSP.
Journal of neural transmission. Supplementum 1994;42():205-18.
1993: O Strada; Etienne C Hirsch; France Javoy-Agid; Charles Duyckaerts; JEAN-JACQUES HAUW; Yves Agid
Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease.
Journal of the neurological sciences 1993;120(1):33-7.
1993: J Villares; Baptiste A Faucheux; O Strada; Etienne C Hirsch; Yves Agid; France Javoy-Agid
Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem.
Brain research 1993;628(1-2):72-6.
1993: María-Trinidad Herrero; Etienne C Hirsch; France Javoy-Agid; Jose A Obeso; Yves Agid
Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum.
Brain research 1993;624(1-2):281-5.
1993: María-Trinidad Herrero; A Kastner; I Perez-Otaño; Etienne C Hirsch; Maria Rosario Luquin; France Javoy-Agid; J Del Río; Jose A Obeso; Yves Agid
Gangliosides and parkinsonism.
Neurology 1993;43(10):2132-4.
1993: C Waeber; Michèle Sebben; C Grossman; France Javoy-Agid; J Bockaert; Aline Dumuis
[3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain.
Neuroreport 1993;4(11):1239-42.
1993: María-Trinidad Herrero; Etienne C Hirsch; A Kastner; Merle Ruberg; Maria Rosario Luquin; J Laguna; France Javoy-Agid; Jose A Obeso; Yves Agid
Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Neuroscience 1993;56(2):499-511.
1993: A Kastner; Etienne C Hirsch; María-Trinidad Herrero; France Javoy-Agid; Yves Agid
Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.
Journal of neurochemistry 1993;61(3):1024-34.
1993: V Blanchard; Rita Raisman-Vozari; M Savasta; Etienne C Hirsch; France Javoy-Agid; Claude Feuerstein; Yves Agid
Cellular quantification of tyrosine hydroxylase in the rat brain by immunoautoradiography.
Journal of neurochemistry 1993;61(2):617-26.
1993: María-Trinidad Herrero; Merle Ruberg; Etienne C Hirsch; A Mouatt; A J Tobin; Yves Agid; Jose A Obeso; France Javoy-Agid
In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels.
Neuroscience letters 1993;157(1):57-61.
1993: P Zhang; Philippe Damier; Etienne C Hirsch; Yves Agid; Irène Ceballos-Picot; Pierre-Marie Sinet; Annie Nicole; M Laurent; France Javoy-Agid
Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon.
Neuroscience 1993;55(1):167-75.
1993: P Anglade; S Tsuji; Etienne C Hirsch; France Javoy-Agid; Yves Agid
Ultrastructural relations between nigrostriatal dopaminergic neurons and cholinergic nerve endings in the human brain.
Histology and histopathology 1993;8(3):501-4.
1993: Baptiste A Faucheux; Etienne C Hirsch; J Villares; F Selimi; Annick Mouatt-Prigent; France Javoy-Agid; JEAN-JACQUES HAUW; Yves Agid
Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.
Journal of neurochemistry 1993;60(6):2338-41.
1993: P Anglade; Etienne C Hirsch; Jean-Philippe Brandel; France Javoy-Agid; Charles Duyckaerts; JEAN-JACQUES HAUW; Yves Agid
Adrenal transplant, dopaminergic neurons, and Parkinson's disease.
Annals of neurology 1993;33(6):662-3.
1993: Patrick Vermersch; André Delacourte; France Javoy-Agid; JEAN-JACQUES HAUW; Yves Agid
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
Annals of neurology 1993;33(5):445-50.
1993: S Lehéricy; Etienne C Hirsch; P Cervera-Piérot; Louis B Hersh; S Bakchine; F Piette; Charles Duyckaerts; JEAN-JACQUES HAUW; France Javoy-Agid; Yves Agid
Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
The Journal of comparative neurology 1993;330(1):15-31.
1993: A Kastner; Etienne C Hirsch; Yves Agid; France Javoy-Agid
Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.
Brain research 1993;606(2):341-5.
1993: Philippe Damier; Etienne C Hirsch; P Zhang; Yves Agid; France Javoy-Agid
Glutathione peroxidase, glial cells and Parkinson's disease.
Neuroscience 1993;52(1):1-6.
1993: Yves Agid; Merle Ruberg; France Javoy-Agid; Etienne C Hirsch; Rita Raisman-Vozari; Sheela Vyas; Baptiste A Faucheux; P Michel; A Kastner; V Blanchard
Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Advances in neurology 1993;60():148-64.
1993: France Javoy-Agid
Parkinson's Disease Brain Bank in Paris: an evolutive bank responding to the exigencies of new neurochemical methodologies.
Journal of neural transmission. Supplementum 1993;39():185-92.
1993: María-Trinidad Herrero; Etienne C Hirsch; A Kastner; Maria Rosario Luquin; France Javoy-Agid; LM Gonzalo; Jose A Obeso; Yves Agid
Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem.
Developmental neuroscience 1993;15(1):37-48.
1992: O Strada; Etienne C Hirsch; France Javoy-Agid; Stéphane Lehéricy; Merle Ruberg; JEAN-JACQUES HAUW; Yves Agid
Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1992;12(12):4766-74.
1992: O Strada; Sheela Vyas; Etienne C Hirsch; Merle Ruberg; Alexis Brice; Yves Agid; France Javoy-Agid
Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(20):9549-53.
1992: A Kastner; Etienne C Hirsch; O Lejeune; France Javoy-Agid; Olivier Rascol; Yves Agid
Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
Journal of neurochemistry 1992;59(3):1080-9.
1992: Etienne C Hirsch; A Mouatt; B Faucheux; Anne-Marie Bonnet; France Javoy-Agid; Ann M Graybiel; Yves Agid
Dopamine, tremor, and Parkinson's disease.
Lancet 1992;340(8811):125-6.
1992: Klaus W Lange; France Javoy-Agid; Yves Agid; Peter Jenner; CD Marsden
Brain muscarinic cholinergic receptors in Huntington's disease.
Journal of neurology 1992;239(2):103-4.
1992: P Bertrand; O Roger; R Houlgatte; France Javoy-Agid; J P Brandel; A Doble; J C Blanchard
Measurement of nerve growth factor-like immunoreactivity in human brain using an anti-mouse-NGF enzyme immunoassay.
Neurochemistry international 1992;20(2):215-8.
1992: P Zhang; Etienne C Hirsch; Philippe Damier; Charles Duyckaerts; France Javoy-Agid
c-fos protein-like immunoreactivity: distribution in the human brain and over-expression in the hippocampus of patients with Alzheimer's disease.
Neuroscience 1992;46(1):9-21.
1991: S Holemans; France Javoy-Agid; Yves Agid; E C Laterre; Jean-Marie Maloteaux
[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy.
Brain research 1991;565(1):154-7.
1991: S Malessa; Etienne C Hirsch; P Cervera; France Javoy-Agid; Charles Duyckaerts; JEAN-JACQUES HAUW; Yves Agid
Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation.
Neurology 1991;41(10):1593-7.
1991: Rita Raisman-Vozari; Etienne C Hirsch; France Javoy-Agid; C Vassort; M Savasta; Claude Feuerstein; J Thibault; Yves Agid
Quantitative autoradiography of tyrosine hydroxylase immunoreactivity in the rat brain.
Journal of neurochemistry 1991;57(4):1212-22.
1991: patricia Gaspar; Charles Duyckaerts; C Alvarez; France Javoy-Agid; B Berger
Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease.
Annals of neurology 1991;30(3):365-74.
1991: David T Dexter; A Carayon; France Javoy-Agid; Yves Agid; F R Wells; Susan E Daniel; Andrew J Lees; Peter Jenner; CD Marsden
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Brain : a journal of neurology 1991;114 ( Pt 4)():1953-75.
1991: Irène Ceballos-Picot; Annie Nicole; Pascale Briand; G Grimber; André Delacourte; A Defossez; France Javoy-Agid; M Lafon; J L Blouin; Pierre-Marie Sinet
Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.
Brain research 1991;552(2):198-214.
1991: G K Lloyd; A Lowenthal; France Javoy-Agid; J Constantidinis
GABAA receptor complex function in frontal cortex membranes from control and neurological patients.
European journal of pharmacology 1991;197(1):33-9.
1991: Etienne C Hirsch; Jean-Philippe Brandel; P Galle; France Javoy-Agid; Yves Agid
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
Journal of neurochemistry 1991;56(2):446-51.
1991: I Ceballos; France Javoy-Agid; André Delacourte; A Defossez; M Lafon; Etienne C Hirsch; Annie Nicole; Pierre-Marie Sinet; Yves Agid
Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains.
Free radical research communications 1991;12-13 Pt 2():571-80.
1991: S Flament; André Delacourte; M Verny; JEAN-JACQUES HAUW; France Javoy-Agid
Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
Acta neuropathologica 1991;81(6):591-6.
1990: M L Harpin; P Delaère; France Javoy-Agid; E Bock; CM Jacque; B Delpech; H Villarroya; Charles Duyckaerts; JEAN-JACQUES HAUW; Nicole Baumann
Glial fibrillary acidic protein and beta A4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type: relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles.
Journal of neuroscience research 1990;27(4):587-94.
1990: V M Mann; J Mark Cooper; France Javoy-Agid; Yves Agid; Peter Jenner; Anthony H V Schapira
Mitochondrial function and parental sex effect in Huntington's disease.
Lancet 1990;336(8717):749.
1990: Jesse Cedarbaum; K F Sheu; B J Harding; John P Blass; France Javoy-Agid; Yves Agid
Deficiency of glutamate dehydrogenase in postmortem brain samples from parkinsonian putamen.
Annals of neurology 1990;28(1):111-2.
1990: Etienne C Hirsch; Charles Duyckaerts; France Javoy-Agid; JEAN-JACQUES HAUW; Yves Agid
Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?
Annals of neurology 1990;27(6):676-82.
1990: Jean-Philippe Brandel; Etienne C Hirsch; Louis B Hersh; France Javoy-Agid
Compartmental ordering of cholinergic innervation in the mediodorsal nucleus of the thalamus in human brain.
Brain research 1990;515(1-2):117-25.
1990: I Ceballos; M Lafon; France Javoy-Agid; Etienne C Hirsch; A Nicole; P M Sinet; Yves Agid
Superoxide dismutase and Parkinson's disease.
Lancet 1990;335(8696):1035-6.
1990: S Dumas; France Javoy-Agid; Etienne C Hirsch; Yves Agid; J Mallet
Tyrosine hydroxylase gene expression in human ventral mesencephalon: detection of tyrosine hydroxylase messenger RNA in neurites.
Journal of neuroscience research 1990;25(4):569-75.
1990: I Ceballos; France Javoy-Agid; André Delacourte; A Defossez; Annie Nicole; Pierre-Marie Sinet
Parkinson's disease and Alzheimer's disease: neurodegenerative disorders due to brain antioxidant system deficiency?
Advances in experimental medicine and biology 1990;264():493-8.
1990: Florence Thibaut; Etienne C Hirsch; R Raisman; France Javoy-Agid; Yves Agid
Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
Neuroscience 1990;37(2):387-98.
1990: France Javoy-Agid; Etienne C Hirsch; Sylvie Dumas; Charles Duyckaerts; Jacques Mallet; Yves Agid
Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.
Neuroscience 1990;38(1):245-53.
1990: Yves Agid; Ann M Graybiel; Merle Ruberg; Etienne C Hirsch; J Blin; Bruno Dubois; France Javoy-Agid
The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
Advances in neurology 1990;53():83-100.
1989: I Ceballos; France Javoy-Agid; Etienne C Hirsch; S Dumas; Pierre Kamoun; Pierre-Marie Sinet; Yves Agid
Localization of copper-zinc superoxide dismutase mRNA in human hippocampus by in situ hybridization.
Neuroscience letters 1989;105(1-2):41-6.
1989: D Scherman; C Desnos; F Darchen; Pierre Pollak; France Javoy-Agid; Yves Agid
Striatal dopamine deficiency in Parkinson's disease: role of aging.
Annals of neurology 1989;26(4):551-7.
1989: David T Dexter; Chris Carter; F R Wells; France Javoy-Agid; Yves Agid; Andrew J Lees; Peter Jenner; CD Marsden
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.
Journal of neurochemistry 1989;52(2):381-9.
1989: Jacques Vignon; I Chaudieu; H Allaoua; L Journod; France Javoy-Agid; Yves Agid; R Chicheportiche
Comparison of [3H] phencyclidine ([3H] PCP) and [3H] N-[1-(2-thienyl) cyclohexyl] piperidine ([3H] TCP) binding properties to rat and human brain membranes.
Life sciences 1989;45(26):2547-55.
1989: Yves Agid; P Cervera; Etienne C Hirsch; France Javoy-Agid; S Lehericy; R Raisman; Merle Ruberg
Biochemistry of Parkinson's disease 28 years later: a critical review.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S126-44.
1989: France Javoy-Agid; B Scatton; Merle Ruberg; R L'Heureux; P Cervera; R Raisman; J M Maloteaux; H Beck; Yves Agid
Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex.
Neuroscience 1989;29(2):251-9.
1988: H Taquet; France Javoy-Agid; Annie Mauborgne; Jean-Jacques Benoliel; Yves Agid; J C Legrand; G Tramu; François Cesselin; Michel Hamon
Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortex.
Neuroscience 1988;27(3):871-83.
1988: Jean-Marie Maloteaux; M A Vanisberg; C Laterre; France Javoy-Agid; Yves Agid; P M Laduron
[3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy.
European journal of pharmacology 1988;156(3):331-40.
1988: J Epelbaum; France Javoy-Agid; A Enjalbert; S Krantic; C Kordon; Yves Agid
Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy.
Journal of the neurological sciences 1988;87(2-3):167-74.
1988: H Taquet; M Nomoto; S Rose; Peter Jenner; France Javoy-Agid; Annie Mauborgne; Jean-Jacques Benoliel; CD Marsden; J C Legrand; Yves Agid
Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment.
Neuropeptides 1988;12(3):105-10.
1988: Laurent Pierot; C Desnos; J Blin; R Raisman; D Scherman; France Javoy-Agid; Merle Ruberg; Yves Agid
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
Journal of the neurological sciences 1988;86(2-3):291-306.
1988: P Cervera; Olivier Rascol; A Ploska; G Gaillard; R Raisman; Charles Duyckaerts; JEAN-JACQUES HAUW; D Scherman; Jean-Louis Montastruc; France Javoy-Agid
Noradrenaline, adrenaline and tyrosine hydroxylase in adrenal medulla from parkinsonian patients.
Journal of neurology, neurosurgery, and psychiatry 1988;51(8):1104-5.
1988: Sylvie Jégou; France Javoy-Agid; C Delbende; D Tranchand-Bunel; D H Coy; Yves Agid; Hubert Vaudry
Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects.
Peptides 1988;9(4):787-93.
1988: Jean-Marie Maloteaux; M A Luabeya; M A Vanisberg; E C Laterre; P M Laduron; France Javoy-Agid; Yves Agid
Benzodiazepine receptors in normal human brain, in Parkinson's disease and in progressive supranuclear palsy.
Brain research 1988;446(2):321-32.
1988: Jean-Marie Maloteaux; E C Laterre; P M Laduron; France Javoy-Agid; Yves Agid
Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 1988;3(3):255-62.
1987: J Epelbaum; France Javoy-Agid; Etienne C Hirsch; JEAN-JACQUES HAUW; C Kordon; S Krantic; Yves Agid
Brain somatostatin concentrations do not decrease in progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 1987;50(11):1526-8.
1987: Etienne C Hirsch; Ann M Graybiel; Charles Duyckaerts; France Javoy-Agid
Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(16):5976-80.
1987: P Delay-Goyet; J M Zajac; France Javoy-Agid; Yves Agid; Bernard P Roques
Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects.
Brain research 1987;414(1):8-14.
1987: H Taquet; France Javoy-Agid; Annie Mauborgne; Jean-Jacques Benoliel; Yves Agid; J C Legrand; M Hamon; François Cesselin
Brain neuropeptides in progressive supranuclear palsy.
Brain research 1987;411(1):178-82.
1987: B Grima; A Lamouroux; C Boni; Jean-Francois Julien; France Javoy-Agid; Jacques Mallet
A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics.
Nature 1987;326(6114):707-11.
1987: R Cash; T Dennis; R L'Heureux; R Raisman; France Javoy-Agid; B Scatton
Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus.
Neurology 1987;37(1):42-6.
1987: R Cash; R Raisman; P Cervera; France Javoy-Agid; Yves Agid
Pitfalls in membrane binding sites studies in post-mortem human brain.
Journal of receptor research 1987;7(1-4):527-54.
1987: Yves Agid; France Javoy-Agid; M Ruberg; B Pillon; Bruno Dubois; Charles Duyckaerts; JEAN-JACQUES HAUW; J C Baron; B Scatton
Progressive supranuclear palsy: anatomoclinical and biochemical considerations.
Advances in neurology 1987;45():191-206.
1986: Peter Jenner; H Taquet; Annie Mauborgne; J T Benoliel; François Cesselin; S Rose; France Javoy-Agid; Yves Agid; CD Marsden
Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset.
Journal of neurochemistry 1986;47(5):1548-51.
1986: B Scatton; T Dennis; R L'Heureux; J C Monfort; Charles Duyckaerts; France Javoy-Agid
Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients.
Brain research 1986;380(1):181-5.
1986: A Camus; France Javoy-Agid; A Dubois; B Scatton
Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine.
Brain research 1986;375(1):135-49.
1986: Charles Duyckaerts; JEAN-JACQUES HAUW; F Bastenaire; F Piette; C Poulain; V Rainsard; France Javoy-Agid; P Berthaux
Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type.
Acta neuropathologica 1986;70(3-4):249-56.
1986: Yves Agid; M Ruberg; Bruno Dubois; Bernard Pillon; G Cusimano; R Raisman; R Cash; F Lhermitte; France Javoy-Agid
Parkinson's disease and dementia.
Clinical neuropharmacology 1986;9 Suppl 2():S22-36.
1986: Yves Agid; H Taquet; F Cesselin; J Epelbaum; France Javoy-Agid
Neuropeptides and Parkinson's disease.
Progress in brain research 1986;66():107-16.
1985: A Sarrieau; France Javoy-Agid; Patrick Kitabgi; M Dussaillant; M Vial; J P Vincent; Yves Agid; William Rostène
Characterization and autoradiographic distribution of neurotensin binding sites in the human brain.
Brain research 1985;348(2):375-80.
1985: M Ruberg; France Javoy-Agid; Etienne C Hirsch; B Scatton; R LHeureux; JEAN-JACQUES HAUW; Charles Duyckaerts; F Gray; A Morel-Maroger; A Rascol
Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
Annals of neurology 1985;18(5):523-9.
1985: Etienne C Hirsch; M Ruberg; M Dardenne; M M Portier; France Javoy-Agid; J F Bach; Yves Agid
Monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease.
Brain research 1985;345(2):374-8.
1985: H Taquet; France Javoy-Agid; P Giraud; J C Legrand; Yves Agid; François Cesselin
Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain.
Brain research 1985;341(2):390-2.
1985: Sylvie Jegou; France Javoy-Agid; C Delbende; M Ruberg; H Vaudry; Yves Agid
Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1985;48(8):842-3.
1985: R Raisman; R Cash; M Ruberg; France Javoy-Agid; Yves Agid
Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.
European journal of pharmacology 1985;113(3):467-8.
1985: J M Allen; A J Cross; T J Crow; France Javoy-Agid; Yves Agid; S R Bloom
Dissociation of neuropeptide Y and somatostatin in Parkinson's disease.
Brain research 1985;337(1):197-200.
1985: J C Monfort; France Javoy-Agid; JEAN-JACQUES HAUW; Bruno Dubois; Yves Agid
Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index.
Brain : a journal of neurology 1985;108 ( Pt 2)():301-13.
1985: B Conte-Devolx; M Grino; A Nieoullon; France Javoy-Agid; Elias Castanas; Viviane Guillaume; M C Tonon; H Vaudry; C Oliver
Corticoliberin, somatocrinin and amine contents in normal and parkinsonian human hypothalamus.
Neuroscience letters 1985;56(2):217-22.
1985: H Schoemaker; C Pimoule; S Arbilla; B Scatton; France Javoy-Agid; S Z Langer
Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease.
Naunyn-Schmiedeberg's archives of pharmacology 1985;329(3):227-35.
1985: Garth Bissette; Charles Nemeroff; M W Decker; J Kizer; Yves Agid; France Javoy-Agid
Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's disease.
Annals of neurology 1985;17(4):324-8.
1985: L Pique; S Jegou; Xavier Bertagna; France Javoy-Agid; D Seurin; M F Proeschel; F Girard; Yves Agid; H Vaudry; Jean Pierre Luton
Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients.
Neuroscience letters 1985;54(2-3):141-6.
1985: Bruno Dubois; JEAN-JACQUES HAUW; M Ruberg; M Serdaru; France Javoy-Agid; Yves Agid
[Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
Revue neurologique 1985;141(3):184-93.
1985: Yves Agid; Anne-Marie Bonnet; M Ruberg; France Javoy-Agid
Pathophysiology of L-dopa-induced abnormal involuntary movements.
Psychopharmacology. Supplementum 1985;2():145-59.
1985: J Epelbaum; Yves Agid; A Enjalbert; M Hamon; France Javoy-Agid; C Kordon; Y Lamour; E Moyse
Somatostatin alterations and brain diseases.
Advances in experimental medicine and biology 1985;188():261-74.
1984: J L Sadoul; F Chécler; P Kitabgi; W Rostène; France Javoy-Agid; J P Vincent
Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects.
Biochemical and biophysical research communications 1984;125(1):395-404.
1984: C Llorens-Cortes; France Javoy-Agid; Yves Agid; H Taquet; J C Schwartz
Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects.
Journal of neurochemistry 1984;43(3):874-7.
1984: B Scatton; A Dubois; France Javoy-Agid; A Camus
Autoradiographic localization of muscarinic cholinergic receptors at various segmental levels of the human spinal cord.
Neuroscience letters 1984;49(3):239-45.
1984: W Mayo; Bruno Dubois; A Ploska; France Javoy-Agid; Yves Agid; M Le Moal; H Simon
Cortical cholinergic projections from the basal forebrain of the rat, with special reference to the prefrontal cortex innervation.
Neuroscience letters 1984;47(2):149-54.
1984: France Javoy-Agid; M Ruberg; L Pique; X Bertagna; H Taquet; J M Studler; F Cesselin; J Epelbaum; Yves Agid
Biochemistry of the hypothalamus in Parkinson's disease.
Neurology 1984;34(5):672-5.
1984: J L Sadoul; P Kitabgi; W Rostène; France Javoy-Agid; Yves Agid; J P Vincent
Characterization and visualization of neurotensin binding to receptor sites in human brain.
Biochemical and biophysical research communications 1984;120(1):206-13.
1984: B Bokobza; M Ruberg; B Scatton; France Javoy-Agid; Yves Agid
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
European journal of pharmacology 1984;99(2-3):167-75.
1984: M Ruberg; B Bokobza; France Javoy-Agid; J C Montfort; Yves Agid
[3H]spiperone binding in the nigrostriatal system in human brain.
European journal of pharmacology 1984;99(2-3):159-65.
1984: Yves Agid; A Ploska; J C Monfort; France Javoy-Agid
Striatal glutamate decarboxylase values, indicative of hospital where patient died.
Lancet 1984;1(8371):280.
1984: Yves Agid; M Ruberg; Bruno Dubois; France Javoy-Agid
Biochemical substrates of mental disturbances in Parkinson's disease.
Advances in neurology 1984;40():211-8.
1984: France Javoy-Agid; M Ruberg; H Taquet; B Bokobza; Yves Agid; patricia Gaspar; B Berger; J N'Guyen-Legros; C Alvarez; F Gray
Biochemical neuropathology of Parkinson's disease.
Advances in neurology 1984;40():189-98.
1983: Bruno Dubois; M Ruberg; France Javoy-Agid; A Ploska; Yves Agid
A subcortico-cortical cholinergic system is affected in Parkinson's disease.
Brain research 1983;288(1-2):213-8.
1983: H Taquet; France Javoy-Agid; M Hamon; J C Legrand; Yves Agid; François Cesselin
Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain.
Brain research 1983;280(2):379-82.
1983: J Epelbaum; M Ruberg; E Moyse; France Javoy-Agid; Bruno Dubois; Yves Agid
Somatostatin and dementia in Parkinson's disease.
Brain research 1983;278(1-2):376-9.
1983: C Pimoule; H Schoemaker; France Javoy-Agid; B Scatton; Yves Agid; S Z Langer
Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's disease.
European journal of pharmacology 1983;95(1-2):145-6.
1983: B Scatton; France Javoy-Agid; L Rouquier; Bruno Dubois; Yves Agid
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
Brain research 1983;275(2):321-8.
1983: France Javoy-Agid; D Grouselle; A Tixier-Vidal; Yves Agid
Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease.
Neuropeptides 1983;3(5):405-10.
1983: Annie Mauborgne; France Javoy-Agid; J C Legrand; Yves Agid; F Cesselin
Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains.
Brain research 1983;268(1):167-70.
1983: T L Perry; France Javoy-Agid; Yves Agid; H C Fibiger
Striatal GABAergic neuronal activity is not reduced in Parkinson's disease.
Journal of neurochemistry 1983;40(4):1120-3.
1983: patricia Gaspar; B Berger; M Gay; M Hamon; F Cesselin; A Vigny; France Javoy-Agid; Yves Agid
Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon. Immunocytochemical localization and relationships.
Journal of the neurological sciences 1983;58(2):247-67.
1983: K G Lloyd; G De Montis; France Javoy-Agid; K Beaumont; A Lowenthal; J Constantinidis; Yves Agid
Glycine receptors in the human brain: characterization of 3H-strychnine binding and status in pathological conditions.
Advances in biochemical psychopharmacology 1983;36():233-8.
1983: M Garbarg; France Javoy-Agid; J C Schwartz; Yves Agid
Brain histidine decarboxylase activity in Parkinson's disease.
Lancet 1983;1(8314-5):74-5.
1982: A Ploska; H Taquet; France Javoy-Agid; patricia Gaspar; François Cesselin; B Berger; M Hamon; J C Legrand; Yves Agid
Dopamine and methionine-enkephalin in human brain.
Neuroscience letters 1982;33(2):191-6.
1982: C Llorens; B Malfroy; J C Schwartz; G Gacel; Bernard P Roques; J Roy; J L Morgat; France Javoy-Agid; Yves Agid
Enkephalin dipeptidyl carboxypeptidase (enkephalinase) activity: selective radioassay, properties, and regional distribution in human brain.
Journal of neurochemistry 1982;39(4):1081-9.
1982: B Scatton; L Rouquier; France Javoy-Agid; Yves Agid
Dopamine deficiency in the cerebral cortex in Parkinson disease.
Neurology 1982;32(9):1039-40.
1982: J M Studler; France Javoy-Agid; F Cesselin; J C Legrand; Yves Agid
CCK-8-Immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients.
Brain research 1982;243(1):176-9.
1982: M Arluison; France Javoy-Agid; Claude Feuerstein; M Tauc; M Conrath-Verrier; P Mailly
Histofluorescence analysis of several systems of catecholaminergic nerve fibres within the rat neostriatum revealed by either restricted lesions of the substantia nigra or gamma-hydroxybutyrate.
Brain research bulletin 1982;9(1-6):355-65.
1982: H Taquet; France Javoy-Agid; François Cesselin; M Hamon; J C Legrand; Yves Agid
Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains.
Brain research 1982;235(2):303-14.
1982: G de Montis; K Beaumont; France Javoy-Agid; Yves Agid; J Constandinidis; A Lowenthal; K G Lloyd
Glycine receptors in the human substantia nigra as defined by [3H]strychnine binding.
Journal of neurochemistry 1982;38(3):718-24.
1982: M Ruberg; A Ploska; France Javoy-Agid; Yves Agid
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
Brain research 1982;232(1):129-39.
1982: J C Schwartz; S de la Baume; C Llorens; B Malfroy; E Soroca; Marie-Claude Fournié-Zaluski; Bernard P Roques; J L Morgat; J Roy; France Javoy-Agid; Yves Agid
Enkephalin dipeptidyl carboxypeptidase ("enkephalinase"): assay, properties, and distribution in human brain and exploration of the active site.
Advances in biochemical psychopharmacology 1982;33():225-34.
1982: France Javoy-Agid; M Ruberg; H Taquet; J M Studler; M Garbarg; C Llorens; J C Schwartz; D Grouselle; K G Lloyd; R Raisman; Yves Agid
Biochemical neuroanatomy of the human substantia nigra (pars compacta) in normal and Parkinsonian subjects.
Advances in neurology 1982;35():151-63.
1981: France Javoy-Agid; A Ploska; Yves Agid
Microtopography of tyrosine hydroxylase, glutamic acid decarboxylase, and choline acetyltransferase in the substantia nigra and ventral tegmental area of control and Parkinsonian brains.
Journal of neurochemistry 1981;37(5):1218-27.
1981: S Z Langer; France Javoy-Agid; R Raisman; M Briley; Yves Agid
Distribution of specific high-affinity binding sites for [3H]imipramine in human brain.
Journal of neurochemistry 1981;37(2):267-71.
1981: H Taquet; France Javoy-Agid; F Cesselin; Yves Agid
Methionine-enkephalin deficiency in brains of patients with Parkinson's disease.
Lancet 1981;1(8234):1367-8.
1981: France Javoy-Agid; H Taquet; A Ploska; C Cherif-Zahar; M Ruberg; Yves Agid
Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's disease.
Journal of neurochemistry 1981;36(6):2101-5.
1980: France Javoy-Agid; Yves Agid
Is the mesocortical dopaminergic system involved in Parkinson disease?
Neurology 1980;30(12):1326-30.
1980: G Barbin; J M Palacios; M Garbarg; J C Schwartz; patricia Gaspar; France Javoy-Agid; Yves Agid
L-Histidine decarboxylase in the human brain: properties and localization.
Journal of neurochemistry 1980;35(2):400-6.
1980: patricia Gaspar; France Javoy-Agid; A Ploska; Yves Agid
Regional distribution of neurotransmitter synthesizing enzymes in the basal ganglia of human brain.
Journal of neurochemistry 1980;34(2):278-83.
1979: Yves Agid; G Barroche; Anne-Marie Bonnet; France Javoy-Agid; G Kato; F Lhermitte; Pierre Pollak; J L Signoret
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1979;30(2):67-71.
1979: J Puymirat; France Javoy-Agid; patricia Gaspar; A Ploska; A Prochiantz; Yves Agid
Post mortem stability and storage in the cold of brain enzymes.
Journal of neurochemistry 1979;32(2):449-54.
1979: France Javoy-Agid
Sensitivity of cholinergic neurons to GABAergic and serotoninergic drugs in the rat striatum.
Applied neurophysiology 1979;42(1-2):75-7.
1978: M E Schwab; France Javoy-Agid; Yves Agid
Labeled wheat germ agglutinin (WGA) as a new, highly sensitive retrograde tracer in the rat brain hippocampal system.
Brain research 1978;152(1):145-50.
1978: L Peyrin; J M Cottet-Emard; France Javoy-Agid; Yves Agid; A Herbet; J Glowinski
Long-term effects of unilateral 6-hydroxydopamine destruction of the dopaminergic nigrostriatal pathway on the urinary excretion of catecholamines (dopamine, norepinephrine, epinephrine) and their metabolites in the rat.
Brain research 1978;143(3):567-72.
1978: M Arluison; Yves Agid; France Javoy-Agid
Dopaminergic nerve endings in the neostriatum of the rat--2. Radioautographic study following local micro-injections of tritiated dopamine.
Neuroscience 1978;3(8):675-83.
1978: M Arluison; Yves Agid; France Javoy-Agid
Dopaminergic nerve endings in the neostriatum of the rat--1. Identification by intracerebral injections of 5-hydroxydopamine.
Neuroscience 1978;3(8):657-73.
1977: P Guyenet; C Euvrard; France Javoy-Agid; A Herbert; J Glowinski
Regional differences in the sensitivity of cholinergic neurons to dopaminergic drugs and quipazine in the rat striatum.
Brain research 1977;136(3):487-500.
1977: P G Guyenet; France Javoy-Agid; C Euvrard; J Glowinski
The effect of drugs on the choline and acetylcholine content of the rat striatum following two methods of sacrifice.
Neuropharmacology 1977;16(6):385-90.
1977: France Javoy-Agid; C Euvrard; A Herbet; J Glowinski
Involvement of the dopamine nigrostriatal system in the picrotoxin effect on striatal acetylcholine levels.
Brain research 1977;126(2):382-6.
1977: France Javoy-Agid; C Euvrard; A Herbet; J Bockaert; A Enjalbert; Yves Agid; J Glowinski
Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.
Naunyn-Schmiedeberg's archives of pharmacology 1977;297(3):233-9.
1977: C Euvrard; France Javoy-Agid; A Herbet; J Glowinski
Effect of quipazine, a serotonin-like drug, on striatal cholinergic interneurones.
European journal of pharmacology 1977;41(3):281-9.
1976: France Javoy-Agid; C Sotelo; A Herbet; Yves Agid
Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
Brain research 1976;102(2):201-15.
1975: France Javoy-Agid; Yves Agid; J Glowinski
Oxotremorine- and atropine-induced changes of dopamine metabolism in the rat striatum.
The Journal of pharmacy and pharmacology 1975;27(9):677-81.
1975: Yves Agid; P Guyenet; J Glowinski; J C Beaujouan; France Javoy-Agid
Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.
Brain research 1975;86(3):488-92.
1975: France Javoy-Agid
Partial selectivity of 6-OHDA induced neuronal degeneration after intraissular injection in the brain with special reference to the nigro-striatal dopamine system.
Journal of neural transmission 1975;37(3):219-27.
1975: P G Guyenet; France Javoy-Agid; Yves Agid; J C Beaujouan; J Glowinski
Dopamine receptors and cholinergic neurons in the rat neostriatum.
Advances in neurology 1975;9():43-51.
1974: Yves Agid; France Javoy-Agid; J Glowimski
Chemical or electrolytic lesion of the substantia nigra: early effects on neostriatal dopamine metabolism.
Brain research 1974;74(1):41-9.
1974: P Guyenet; Yves Agid; France Javoy-Agid; J C Beaujouan; J Glowinski
[Selective action of neuroleptics on the cholinergic neurons of the neostriatum in the rat: antagonism to apomorphine].
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1974;278(21):2679-82.
1974: France Javoy-Agid; Yves Agid; D Bouvet; J Glowinski
Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.
Brain research 1974;68(2):253-60.
1974: France Javoy-Agid; Yves Agid; D Bouvet; J Glowinski
In vivo estimation of tyrosine hydroxylation in the dopaminergic terminals of the rat neostriatum.
The Journal of pharmacy and pharmacology 1974;26(3):179-85.
1973: Yves Agid; France Javoy-Agid; J Glowinski
Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.
Nature: New biology 1973;245(144):150-1.
1973: Yves Agid; France Javoy-Agid; J Glowinski; D Bouvet; C Sotelo
Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity.
Brain research 1973;58(2):291-301.
1973: C Sotelo; France Javoy-Agid; Yves Agid; J Glowinski
Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study.
Brain research 1973;58(2):269-90.
1973: Yves Agid; France Javoy-Agid; Moussa B H Youdim
Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6-hydroxydopamine lesion of the nigrostriatal pathway.
British journal of pharmacology 1973;48(1):175-8.
1973: France Javoy-Agid; Moussa B H Youdim; Yves Agid; J Glowinski
Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
Journal of neural transmission 1973;34(4):279-89.
1972: France Javoy-Agid; Yves Agid; D Bouvet; J Glowinski
Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum.
The Journal of pharmacology and experimental therapeutics 1972;182(3):454-63.
1972: J Gowinski; M J Besson; A Cheramy; France Javoy-Agid; A M Thierry
[Characteristics and functions of intraneuronal compartments of monoamines in the central nervous system].
Revue neurologique 1972;127(1):1-22.
1972: J Glowinski; M Hamon; France Javoy-Agid; Y Morot-Gaudry
Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
Advances in biochemical psychopharmacology 1972;5():423-39.
1971: France Javoy-Agid; J Glowinski
Dynamic characteristic of the 'functional compartment' of dopamine in dopaminergic terminals of the rat striatum.
Journal of neurochemistry 1971;18(7):1305-11.
1970: France Javoy-Agid; M Hamon; J Glowinski
Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus.
European journal of pharmacology 1970;10(2):178-88.
1970: M Hamon; France Javoy-Agid; C Kardon; J Glowinski
Synthesis and release of serotonin in the median eminence of the rat.
Life sciences 1970;9(3):167-73.
1969: France Javoy-Agid; M Hamon; J Glowinski
[Local metabolism of catecholamines in various nuclei of the brain in rats].
Journal de physiologie 1969;61 Suppl 2():323.
1968: C Kordon; France Javoy-Agid; G Vassent; J Glowinski
Blockade of superovulation in the immature rat by increased brain serotonin.
European journal of pharmacology 1968;4(2):169-74.
1968: A M Thierry; France Javoy-Agid; J Glowinski; S S Kety
Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover.
The Journal of pharmacology and experimental therapeutics 1968;163(1):163-71.
1968: France Javoy-Agid; J Glowinski; C Kordon
Effets of adrenalectomy on the turnover of norepinephrine in the rat brain.
European journal of pharmacology 1968;4(1):103-4.
1967: S S Kety; France Javoy-Agid; A M Thierry; L Julou; J Glowinski
A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat.
Proceedings of the National Academy of Sciences of the United States of America 1967;58(3):1249-54.